Laboratories are able to participate in any, or all of our immmunocytochemistry Modules and in-situ hybridisation Modules
Modules you choose will depend on your service scope and areas of special interest.
Laboratories are able to participate in any, or all of our immmunocytochemistry Modules and in-situ hybridisation Modules
Modules you choose will depend on your service scope and areas of special interest.
This module offers three assessment runs per year with the assessment of two antigens at each run.
This module offers three assessment runs per year with the assessment of ER at each run
This module offers three assessment runs per year with the assessment of both ER and PgR at each run
This module offers three assessment runs per year with the assessment of HER2 at each run. This assessment is designed for those undertaking HER2 staining in the breast clinical setting.
This module offers three assessment runs per year with the assessment of two antigens at each run. The antigens chosen are tailored to be applicable to a specialist lymphoma diagnostic service.
This module offers three assessment runs per year with the assessment of two antigens at each run
This module offers three assessment runs per year with the assessment of two antigens at each run on cytospin or cell block preparations. Many of the antigens chosen will cross-over with the General Pathology module, but the UK NEQAS materials are of the type seen in the cytology department.
This module offers three assessment runs per year with the assessment of two antigens at each run.
CD117 is always the requested. The second antigen will be chosen from either: DOG-1 or CD34 or Desmin or S100.
This module offers three assessment runs per year on samples of gastric cancer of varying HER2 membrane protein expression. This module is designed for those staining for HER2 in the gastric setting.
This module offers three assessment runs per year on cell lines and tissue samples of varying degrees of HER2 gene status.
This module offers three assessment runs per year on cell lines and tissue samples of varying degrees of ALK expression.
This module offers three assessment runs per year on cell lines and tissue samples of varying degrees of PD-L1 expression.
This module offers three assessment runs per year on cell lines and tissue samples of known ALK and ROS1 gene status.
This module offers three assessment runs per year with the assessment of two paired antigens at each run. MLH1 & PMS2 OR MSH2 & MSH6 will be requested alternately.
This module offers three assessment runs per year on cell lines of varying degrees of ROS1 expression.
This module offers three assessment runs per year on breast cancer tissues and cell lines of varying degrees of PD-L1 expression.
This module offers three assessment runs per year on breast cancer tissues and cell lines of varying degrees of Ki-67 expression.
This module offers three assessment runs per year on SCC Head & Neck tumours and cell lines of varying degrees of p16 expression.
This module offers three assessment runs per year on SCC Head & Neck tumours and cell lines of varying degrees of high-risk HPV expression.
This module offers three assessment runs per year. It is designed to test your ability to stain breast cancer specimens for low-level expression of HER2. Staining and interpretation are both assessed.